Paola Lanfiuti Baldi

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

Alessio Cortellini, Federico Bozzetti, Pierpaolo Palumbo et al. · Scientific Reports · 2020 · 91 citations · Full text

Medicine, Oncology, Radiology +17

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

G. Cianci, Micaela Morelli, Katia Cannita et al. · British Journal of Cancer · 2003 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

Gemma Bruera, A. Santomaggio, Katia Cannita et al. · BMC Cancer · 2010 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience

Alessandro Parisi, Eleonora Palluzzi, Alessio Cortellini et al. · Clinical & Translational Oncology · 2019 · 32 citations

Medicine, Oncology, Pharmacology +17

Effectiveness of Liver Metastasectomies in Patients With Metastatic Colorectal Cancer Treated With FIr-B/FOx Triplet Chemotherapy Plus Bevacizumab

Gemma Bruera, Katia Cannita, Felice Giuliante et al. · Clinical Colorectal Cancer · 2011 · 29 citations

Medicine, Oncology, Surgery +16